Use of a Screening Tool Improves Appropriate Referral to an Electrophysiologist for Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death-Reference-Cited by-同舟云学术

Use of a Screening Tool Improves Appropriate Referral to an Electrophysiologist for Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death

Published:2011-03 Issue:2 Volume:4 Page:152-156
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Gravelin Laura M.¹,Yuhas Jennifer¹,Remetz Michael¹,Radford Martha¹,Foley John¹,Lampert Rachel¹

Affiliation:

1. From the Brown University School of Medicine (L.M.G.), Providence, RI; Yale University School of Medicine (J.Y., M. Remetz, J.F., R.L.), New Haven, CT; New York University School of Medicine (M. Radford), New York, NY; and Norwich Cardiology Associates (J.F.), Norwich, CT.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Implantable Cardioverter-Defibrillators

2. Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

3. A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

4. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

5. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-related similarities and differences in responses to heart failure therapies;Nature Reviews Cardiology;2024-03-08

2. Disparities in Referral and Utilization of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death;Canadian Journal of Cardiology;2023-11

3. Electronic Health Record Embedded Strategies for Improving Care of Patients With Heart Failure;Current Heart Failure Reports;2023-08

4. Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction;American Heart Journal Plus: Cardiology Research and Practice;2022-07

5. Evaluation of potential underuse of cardiac resynchronization therapy for heart failure with reduced ejection fraction;Journal of Arrhythmia;2021-10-13